UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 63

Sortiert nach

A Double-Blind, Placebo-Controlled, Phase II Study to Determine the Efficacy, Safety, Tolerability and Pharmacokinetics of a Controlled Release (CR) Formulation of Mazindol in Adults with DSM-5 Attention-Deficit/Hyperactivity Disorder (ADHD)

CNS drugs, 2018-03, Vol.32 (3), p.289-301

2018

Volltextzugriff (PDF)

Evaluating dopamine reward pathway in ADHD: clinical implications

JAMA : the journal of the American Medical Association, 2009-09, Vol.302 (10), p.1084

2009

Volltextzugriff (PDF)

The Preschool Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS) 6-Year Follow-Up

Journal of the American Academy of Child and Adolescent Psychiatry, 2013-03, Vol.52 (3), p.264-278.e2

2013

Volltextzugriff (PDF)

Methylphenidate-elicited dopamine increases in ventral striatum are associated with long-term symptom improvement in adults with attention deficit hyperactivity disorder

The Journal of neuroscience, 2012-01, Vol.32 (3), p.841-849

2012

Volltextzugriff (PDF)

The Complete Guide to ADHD: Nature, Diagnosis, and Treatment

Journal of the American Academy of Child and Adolescent Psychiatry, 2021-07, Vol.60 (7), p.925-927

Wigal, Tim

2021

Volltextzugriff (PDF)

Guanfacine Extended Release in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: A Placebo-Controlled Trial

Journal of the American Academy of Child and Adolescent Psychiatry, 2009-02, Vol.48 (2), p.155-165

2009

Volltextzugriff (PDF)

25.2 Measuring Symptomatic Improvements in the Context of Functional Impairment: The Target Impairment Scale

Journal of the American Academy of Child and Adolescent Psychiatry, 2018-10, Vol.57 (10), p.S307-S307

Wigal, Tim

2018

Volltextzugriff (PDF)

Pharmacotherapy of the Preschool ADHD Treatment Study (PATS) Children Growing Up

Journal of the American Academy of Child and Adolescent Psychiatry, 2015-07, Vol.54 (7), p.550-556

2015

Volltextzugriff (PDF)

The Biopharmaceutics Risk Assessment Roadmap for Optimizing Clinical Drug Product Performance

Journal of pharmaceutical sciences, 2014-11, Vol.103 (11), p.3377-3397

2014

Volltextzugriff (PDF)

Prevalence of ADHD symptoms in patients with congenital heart disease

Pediatrics international, 2012-12, Vol.54 (6), p.838-843

2012

Volltextzugriff (PDF)

The reinforcing effects of nicotine and stimulant medication in the everyday lives of adult smokers with ADHD: A preliminary examination

Nicotine & tobacco research, 2006-02, Vol.8 (1), p.37-47

2006

Volltextzugriff (PDF)

A Laboratory School Comparison of Mixed Amphetamine Salts Extended Release (Adderall XR®) and Atomoxetine (Strattera®) in School-Aged Children With Attention Deficit/Hyperactivity Disorder

Journal of attention disorders, 2005-08, Vol.9 (1), p.275-289

2005

Volltextzugriff (PDF)

Motivation deficit in ADHD is associated with dysfunction of the dopamine reward pathway

Molecular psychiatry, 2011-11, Vol.16 (11), p.1147-1154

2011

Volltextzugriff (PDF)

The Time Course of Effect of Multilayer-Release Methylphenidate Hydrochloride Capsules: A Randomized, Double-Blind Study of Adults With ADHD in a Simulated Adult Workplace Environment

Journal of attention disorders, 2020-02, Vol.24 (3), p.373-383

2020

Volltextzugriff (PDF)

Efficacy and Safety of Immediate-Release Methylphenidate Treatment for Preschoolers With ADHD

Journal of the American Academy of Child and Adolescent Psychiatry, 2006-11, Vol.45 (11), p.1284-1293

2006

Volltextzugriff (PDF)

Safety and Efficacy of Centanafadine Sustained-Release in Adults With Attention-Deficit Hyperactivity Disorder: Results of Phase 2 Studies

Neuropsychiatric disease and treatment, 2020-01, Vol.16, p.1411-1426

2020

Volltextzugriff (PDF)

1.52 A Phase II Study to Determine the Efficacy, Safety, Tolerability, and Pharmacokinetics of a Controlled Release (CR) Formulation of Mazindol in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)

Journal of the American Academy of Child and Adolescent Psychiatry, 2017-10, Vol.56 (10), p.S169-S170

2017

Volltextzugriff (PDF)

Safety and Tolerability of Methylphenidate in Preschool Children With ADHD

Journal of the American Academy of Child and Adolescent Psychiatry, 2006-11, Vol.45 (11), p.1294-1303

2006

Volltextzugriff (PDF)

Stimulant-Related Reductions of Growth Rates in the PATS

Journal of the American Academy of Child and Adolescent Psychiatry, 2006-11, Vol.45 (11), p.1304-1313

2006

Volltextzugriff (PDF)

A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (the Comacs Study)

Pediatrics (Evanston), 2004-03, Vol.113 (3 Pt 1), p.e206

2004

Volltextzugriff (PDF)

Academic, behavioral, and cognitive effects of OROS® methylphenidate on older children with attention-deficit/hyperactivity disorder

Journal of child and adolescent psychopharmacology, 2011-04, Vol.21 (2), p.121

2011

Volltextzugriff (PDF)

Pharmacogenetics of Methylphenidate Response in Preschoolers With ADHD

Journal of the American Academy of Child and Adolescent Psychiatry, 2006-11, Vol.45 (11), p.1314-1322

2006

Volltextzugriff (PDF)

Rationale, Design, and Methods of the Preschool ADHD Treatment Study (PATS)

Journal of the American Academy of Child and Adolescent Psychiatry, 2006-11, Vol.45 (11), p.1275-1283

2006

Volltextzugriff (PDF)

35.1 Medication and Maturation in Girls and Boys With ADHD in the MTA

Journal of the American Academy of Child and Adolescent Psychiatry, 2018-10, Vol.57 (10), p.S323-S323

2018

Volltextzugriff (PDF)

Clinical presentation of attention-deficit/hyperactivity disorder in preschool children: the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS)

Journal of child and adolescent psychopharmacology, 2007-11, Vol.17 (5), p.547

2007

Volltextzugriff (PDF)

1 – 25 von 63

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(54)
Mit Volltextzugriff
(48)

Publikationsform

Sprache

Englisch
(63)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(40)
Science & Technology
(40)
Female
(36)
Attention Deficit Hyperactivity Disorder
(35)
Humans
(34)
Male
(32)
Psychiatry
(24)
Attention Deficit Disorder With Hyperactivity - Drug Therapy
(22)
Hyperactivity
(21)
Drug Therapy
(20)
Pediatrics
(20)
Social Sciences
(20)
Biological And Medical Sciences
(19)
Central Nervous System Stimulants - Therapeutic Use
(19)
Psychology
(19)
Preschool Children
(17)
Child
(16)
Child, Preschool
(16)
Methylphenidate - Therapeutic Use
(16)
Psychology. Psychoanalysis. Psychiatry
(16)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A Double-Blind, Placebo-Controlled, Phase II Study to Determine the Efficacy, Safety, Tolerability and Pharmacokinetics of a Controlled Release (CR) Formulation of Mazindol in Adults with DSM-5 Attention-Deficit/Hyperactivity Disorder (ADHD)

Evaluating dopamine reward pathway in ADHD: clinical implications

The Preschool Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS) 6-Year Follow-Up

Methylphenidate-elicited dopamine increases in ventral striatum are associated with long-term symptom improvement in adults with attention deficit hyperactivity disorder

The Complete Guide to ADHD: Nature, Diagnosis, and Treatment

Guanfacine Extended Release in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: A Placebo-Controlled Trial

25.2 Measuring Symptomatic Improvements in the Context of Functional Impairment: The Target Impairment Scale

Pharmacotherapy of the Preschool ADHD Treatment Study (PATS) Children Growing Up

The Biopharmaceutics Risk Assessment Roadmap for Optimizing Clinical Drug Product Performance

Prevalence of ADHD symptoms in patients with congenital heart disease

The reinforcing effects of nicotine and stimulant medication in the everyday lives of adult smokers with ADHD: A preliminary examination

A Laboratory School Comparison of Mixed Amphetamine Salts Extended Release (Adderall XR®) and Atomoxetine (Strattera®) in School-Aged Children With Attention Deficit/Hyperactivity Disorder

Motivation deficit in ADHD is associated with dysfunction of the dopamine reward pathway

The Time Course of Effect of Multilayer-Release Methylphenidate Hydrochloride Capsules: A Randomized, Double-Blind Study of Adults With ADHD in a Simulated Adult Workplace Environment

Efficacy and Safety of Immediate-Release Methylphenidate Treatment for Preschoolers With ADHD

Safety and Efficacy of Centanafadine Sustained-Release in Adults With Attention-Deficit Hyperactivity Disorder: Results of Phase 2 Studies

1.52 A Phase II Study to Determine the Efficacy, Safety, Tolerability, and Pharmacokinetics of a Controlled Release (CR) Formulation of Mazindol in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)

Safety and Tolerability of Methylphenidate in Preschool Children With ADHD

Stimulant-Related Reductions of Growth Rates in the PATS

A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (the Comacs Study)

Academic, behavioral, and cognitive effects of OROS® methylphenidate on older children with attention-deficit/hyperactivity disorder

Pharmacogenetics of Methylphenidate Response in Preschoolers With ADHD

Rationale, Design, and Methods of the Preschool ADHD Treatment Study (PATS)

35.1 Medication and Maturation in Girls and Boys With ADHD in the MTA

Clinical presentation of attention-deficit/hyperactivity disorder in preschool children: the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS)

Suchergebnisse filtern